THE Philippine Food and Drug Administration has approved a certificate of product registration (CPR) for a local drug company to manufacture human-grade ivermectin as an "anti-nematode drug".

FDA Director-General Rolando Enrique Domingo confirmed to The Manila Times that Lloyd Laboratories has been given CPR.

Premium + Digital Edition

Ad-free access


P 80 per month
(billed annually at P 960)
  • Unlimited ad-free access to website articles
  • Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)

TRY FREE FOR 14 DAYS
See details
See details